Diabetes

News

Novo Nordisk weakens again on interim results readout

Novo Nordisk's already depressed share price has fallen again this morning, despite reporting an 18% increase in sales in the first half of this year.

News

Lilly trumpets heart health data with Mounjaro

Eli Lilly has raised the stakes in its rivalry with Novo Nordisk on GLP-1 drugs for diabetes, with new data for Mounjaro on cardiovascular outcomes.

News

Novo Nordisk slumps as it cuts sales forecast, names new CEO

Novo Nordisk has a new CEO, facing an uphill battle to restore the fortunes of its US business as diabetes and obesity drugs come under pressure.

News

'Diabetes Barbie' launches with medtech accessories

Barbie just took a step forward for inclusivity and representation with the launch of a doll with type 1 diabetes.

News

Boehringer raises hope of oral drug for diabetic eye disease

Boehringer has started a phase 2 trial of an oral therapy that could help people with diabetic macular oedema avoid regular injections into the eye.

News

Two male scientists analysing results on a computer screen

GlucoModicum's non-invasive CGM nears first filing

Finland's GlucoModicum thinks it is in the lead in the race to bring a non-invasive continuous glucose monitor (CGM) to market.

Novo Nordisk weakens again on interim results readout

Lilly trumpets heart health data with Mounjaro

Novo Nordisk slumps as it cuts sales forecast, names new CEO

'Diabetes Barbie' launches with medtech accessories

Boehringer raises hope of oral drug for diabetic eye disease

GlucoModicum's non-invasive CGM nears first filing

Novo Nordisk fight with KBP Bio will go to arbitration

Discover a new era of healthcare panel engagement: Grounded ...

Diabetes

Editor's Picks